A Circulating Panel of circRNA Biomarkers for the Noninvasive and Early Detection of Pancreatic Ductal Adenocarcinoma
Caiming Xu(Dalian Medical University), Ajay Goel(City of Hope), Song Cheol Kim(Ulsan College), Erkut Borazanci(HonorHealth), Eunsung Jun(Asan Medical Center), Daniel D. Von Hoff(Translational Genomics Research Institute), Akinobu Taketomi(Hokkaido University), Guixin Zhang(Dalian Medical University), Dong Shang(Dalian Medical University), Yoshinaga Okugawa(Mie University Hospital), John S. Bolton(NSABP Foundation), Yuji Toiyama(Mie University)
Cited by 87
Related Papers
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
|New England Journal of Medicine|2013|6.6k
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.
|Journal of Clinical Oncology|1997|5.9k
Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers
|Gastroenterology|2015|814
Pathways of Colorectal Carcinogenesis
|Gastroenterology|2019|594
Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers
|Proceedings of the National Academy of Sciences|2017|577